CTNNBIP1 and atherosclerosis: Interestingly, CTNNBIP1 has been previously confirmed to be a direct target of miR-215-5p in various diagnoses, including human glioma [37], diabetic nephropathy, or atherosclerosis [38], and promoting the tumor growth through Wnt/β-catenin signaling pathway.